한글목차

세포은행 아웃소싱 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 128억 6,000만 달러에서 2026년에는 147억 6,000만 달러로, CAGR 14.8%로 성장할 것으로 예상됩니다. 지난 수년간의 성장은 바이오의약품 제조 확대, 외주 바이오프로세스 서비스 의존도 증가, 백신 생산 프로그램 확대, 표준화된 세포주 보존의 필요성 증대, 제약사의 비용 최적화 등이 주요 요인으로 분석됩니다.

세포은행 아웃소싱 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 241억 2,000만 달러에 달하고, CAGR은 13.1%를 기록할 전망입니다. 예측 기간 동안의 성장은 세포 및 유전자 치료제 파이프라인의 급증, 바이러스 벡터 제조에 대한 수요 증가, 세포주 추적성에 대한 규제 당국의 관심 증가, 맞춤형 의료 개발의 성장, 위탁개발생산기관(CDMO)의 확대에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 GMP 준수 세포은행 서비스 아웃소싱 증가, 다종 세포 취급 능력에 대한 수요 증가, 세포주 문서화 및 추적성 표준화, 첨단 치료용 바이러스 벡터 세포은행 확대, 장기 세포은행 보관 계약에 대한 선호도 증가 등을 들 수 있습니다. 등을 꼽을 수 있습니다.

향후 몇 년 동안 만성질환의 유병률 증가는 세포은행 아웃소싱 시장의 확대를 촉진할 것으로 예상됩니다. 만성질환은 천천히 발병하고 장기간 지속되는 건강 상태를 말하며, 보통 지속적인 치료가 필요한 질환을 말합니다. 이러한 부담의 증가는 라이프스타일의 변화, 고령화, 유전적 요인에 기인합니다. 세포은행 아웃소싱 시장은 치료제 개발에 필수적인 세포의 효과적인 보존, 유지, 취급을 위한 전용 시설, 최첨단 도구, 전문지식을 제공하여 만성질환 연구를 지원합니다. 예를 들어, 2025년 4월 영국에 기반을 둔 전국 조직인 NHS Confederation은 2035년까지 영국 인구의 약 17%가 4개 이상의 만성질환을 관리하고 있을 것으로 예상했습니다. 이처럼 만성질환의 증가는 세포은행 아웃소싱 시장의 확대를 촉진하고 있습니다.

세포은행 아웃소싱 시장의 주요 기업들은 단일 세포 효능 특성 평가 플랫폼과 같은 첨단 기술 개발을 우선시하여 보다 정확한 효능 평가를 제공하고 우수한 세포 치료 창출을 지원하고 있습니다. 단일 세포 효능 특성화 플랫폼은 다양한 세포 집단에서 개별 세포의 기능적 특성과 치료 가능성을 평가하기 위해 구축된 고급 분석 도구로, 연구 및 임상 적용을 위해 세포의 동역학, 효능, 작용 기전에 대한 상세한 지식을 제공합니다. 예를 들어, 2024년 1월 이탈리아의 생명공학 기업 Cellply Srl은 효능 분석과 면역 표현형 분석을 결합한 종합적인 단일 세포 효능 특성화 플랫폼 'VivaCyte'를 발표했습니다. 이 플랫폼은 완전 자동화, 단일 세포 수준의 정확도, 신속한 다중 매개변수 기능 평가를 실현하여 개발 기간, 비용, 리스크를 줄이는 동시에 다양한 공정 변동 하에서 다양한 세포 치료 후보물질에 대한 철저한 평가를 가능하게 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Cell banking outsourcing involves hiring outside companies to create, sustain, and oversee repositories of vital cell lines used in biotechnology and pharmaceutical sectors, including drug development and biomanufacturing. This approach guarantees that cells are processed, preserved, and cared for according to uniform standards, promoting reliability and uniformity.

The primary categories of cell banking outsourcing encompass master cell banking, working cell banking, and viral cell banking. Master cell banking (MCB) involves a stock of thoroughly characterized cells derived from a single clone, designed to act as the initial source for manufacturing therapeutic products like biologics or cell therapies. It covers diverse cell types, including stem cell banking and non-stem cell banking, across multiple stages such as bank storage, bank characterization and testing, and bank preparation.

Tariffs have created both operational challenges and strategic shifts for the cell banking outsourcing market by increasing the cost of imported cryogenic equipment, bioprocessing consumables, and quality testing reagents essential for cell bank preparation and characterization. these cost pressures have most significantly impacted viral cell banking and master cell banking segments, particularly across north america and europe where regulatory-grade inputs are heavily imported. asia-pacific outsourcing hubs have also experienced delays due to cross-border logistics disruptions. however, tariffs have encouraged regional localization of cell banking infrastructure and strengthened domestic outsourcing capabilities, supporting long-term supply chain resilience.

The cell banking outsourcing market research report is one of a series of new reports from The Business Research Company that provides cell banking outsourcing market statistics, including cell banking outsourcing industry global market size, regional shares, competitors with a cell banking outsourcing market share, detailed cell banking outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the cell banking outsourcing industry. This cell banking outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell banking outsourcing market size has grown rapidly in recent years. It will grow from $12.86 billion in 2025 to $14.76 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to growth in biologics manufacturing, increasing reliance on outsourced bioprocessing services, expansion of vaccine production programs, rising need for standardized cell line storage, cost optimization by pharmaceutical companies.

The cell banking outsourcing market size is expected to see rapid growth in the next few years. It will grow to $24.12 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to surge in cell and gene therapy pipelines, rising demand for viral vector manufacturing, increasing regulatory focus on cell line traceability, growth of personalized medicine development, expansion of contract development and manufacturing organizations. Major trends in the forecast period include rising outsourcing of gmp-compliant cell banking services, increasing demand for multi-species cell banking capabilities, standardization of cell line documentation and traceability, expansion of viral and vector cell banking for advanced therapies, growing preference for long-term cell bank storage agreements.

The growing prevalence of chronic diseases is anticipated to boost the cell banking outsourcing market in the years ahead. Chronic diseases represent long-term health conditions that emerge slowly and endure for prolonged durations, typically demanding continuous care. This escalating burden stems from shifts in lifestyles, aging demographics, and hereditary factors. The cell banking outsourcing market aids research into chronic diseases by offering dedicated facilities, cutting-edge tools, and specialized expertise for the effective storage, maintenance, and handling of cells essential to therapy development. For instance, in April 2025, the NHS Confederation-a UK-based national body-reported that by 2035, around 17% of the UK population might be managing four or more chronic conditions. Thus, the increasing load of chronic diseases is fueling expansion in the cell banking outsourcing market.

Major companies in the cell banking outsourcing market are prioritizing the creation of cutting-edge technologies, like single-cell potency characterization platforms, to provide more accurate potency evaluations and aid in producing superior cell therapies. A single-cell potency characterization platform is a sophisticated analytical tool built to assess the functional attributes and therapeutic promise of individual cells in diverse cell populations, offering detailed understanding of cell dynamics, potency, and modes of action for research and clinical applications. For example, in January 2024, Cellply Srl, an Italian biotechnology firm, introduced VivaCyte, a comprehensive single-cell potency characterization platform that combines potency analysis with immunophenotyping, offering full automation, single-cell precision, and fast multi-parameter functional evaluation to cut down on development timelines, expenses, and risks while allowing thorough assessment of various cell therapy candidates across different process variations.

In April 2025, Artis BioSolutions LLC, a US-based healthcare technology company, acquired Landmark Bio for an undisclosed sum. Through this acquisition, Artis seeks to expand Landmark's expertise in translational research and GMP manufacturing, speeding up the development and commercialization of advanced cell and gene therapies. Landmark Bio, PBLLC, is a US-based life sciences firm offering cell banking outsourcing services.

Major companies operating in the cell banking outsourcing market are Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Labcorp Drug Development, Covance Inc., SGS Life Sciences, Sartorius AG, BioReliance, Cleancells, Clean Biologics, Texcell, Goodwin Biotechnology Inc., Perfectus Biomed Limited, BioStorage Technologies Inc., Toxikon Corp., PX'Therapeutics SA, Sigma-Aldrich Co. Ltd., Transcell Biolife Pvt Ltd, Eurofins Scientific SE, ViruSure GmbH

North America was the largest region in the cell banking outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell banking outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell banking outsourcing market includes revenues earned by entities by providing services, such as cell line establishment, cryopreservation, cell line characterization, facilitating the distribution of cell lines, and quality control. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Banking Outsourcing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cell banking outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell banking outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell banking outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Master Cell Banking; Working Cell Banking; Viral Cell Banking
• 2) By Cell Type: Stem Cell Banking; Non-Stem Cell Banking
• 3) By Phase: Bank Storage; Bank Characterization And Testing; Bank Preparation
• Subsegments:
• 1) By Master Cell Banking: Human Master Cell Bank; Animal Master Cell Bank
• 2) By Working Cell Banking: Human Working Cell Bank; Animal Working Cell Bank
• 3) By Viral Cell Banking: Virus Bank For Vaccine Production; Viral Vector Bank For Gene Therapy; Adenovirus Bank
• Companies Mentioned: Lonza Group Ltd.; WuXi AppTec; Charles River Laboratories; Labcorp Drug Development; Covance Inc.; SGS Life Sciences; Sartorius AG; BioReliance; Cleancells; Clean Biologics; Texcell; Goodwin Biotechnology Inc.; Perfectus Biomed Limited; BioStorage Technologies Inc.; Toxikon Corp.; PX'Therapeutics SA; Sigma-Aldrich Co. Ltd.; Transcell Biolife Pvt Ltd; Eurofins Scientific SE; ViruSure GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Cell Banking Outsourcing Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Cell Banking Outsourcing Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Cell Banking Outsourcing Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Cell Banking Outsourcing Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Outsourcing Of Gmp-Compliant Cell Banking Services
  • 4.2.2 Increasing Demand For Multi-Species Cell Banking Capabilities
  • 4.2.3 Standardization Of Cell Line Documentation And Traceability
  • 4.2.4 Expansion Of Viral And Vector Cell Banking For Advanced Therapies
  • 4.2.5 Growing Preference For Long-Term Cell Bank Storage Agreements

5. Cell Banking Outsourcing Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Companies
• 5.3 Contract Development And Manufacturing Organizations (Cdmos)
• 5.4 Cell And Gene Therapy Developers
• 5.5 Vaccine Manufacturers

6. Cell Banking Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cell Banking Outsourcing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Cell Banking Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Cell Banking Outsourcing Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Cell Banking Outsourcing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Cell Banking Outsourcing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cell Banking Outsourcing Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cell Banking Outsourcing Market Segmentation

• 9.1. Global Cell Banking Outsourcing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Master Cell Banking, Working Cell Banking, Viral Cell Banking
• 9.2. Global Cell Banking Outsourcing Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Stem Cell Banking, Non-Stem Cell Banking
• 9.3. Global Cell Banking Outsourcing Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bank Storage, Bank Characterization And Testing, Bank Preparation
• 9.4. Global Cell Banking Outsourcing Market, Sub-Segmentation Of Master Cell Banking, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Human Master Cell Bank, Animal Master Cell Bank
• 9.5. Global Cell Banking Outsourcing Market, Sub-Segmentation Of Working Cell Banking, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Human Working Cell Bank, Animal Working Cell Bank
• 9.6. Global Cell Banking Outsourcing Market, Sub-Segmentation Of Viral Cell Banking, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

10. Cell Banking Outsourcing Market Regional And Country Analysis

• 10.1. Global Cell Banking Outsourcing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Cell Banking Outsourcing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cell Banking Outsourcing Market

• 11.1. Asia-Pacific Cell Banking Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cell Banking Outsourcing Market

• 12.1. China Cell Banking Outsourcing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cell Banking Outsourcing Market

• 13.1. India Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cell Banking Outsourcing Market

• 14.1. Japan Cell Banking Outsourcing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cell Banking Outsourcing Market

• 15.1. Australia Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cell Banking Outsourcing Market

• 16.1. Indonesia Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cell Banking Outsourcing Market

• 17.1. South Korea Cell Banking Outsourcing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cell Banking Outsourcing Market

• 18.1. Taiwan Cell Banking Outsourcing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cell Banking Outsourcing Market

• 19.1. South East Asia Cell Banking Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cell Banking Outsourcing Market

• 20.1. Western Europe Cell Banking Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cell Banking Outsourcing Market

• 21.1. UK Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cell Banking Outsourcing Market

• 22.1. Germany Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cell Banking Outsourcing Market

• 23.1. France Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cell Banking Outsourcing Market

• 24.1. Italy Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cell Banking Outsourcing Market

• 25.1. Spain Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cell Banking Outsourcing Market

• 26.1. Eastern Europe Cell Banking Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cell Banking Outsourcing Market

• 27.1. Russia Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cell Banking Outsourcing Market

• 28.1. North America Cell Banking Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cell Banking Outsourcing Market

• 29.1. USA Cell Banking Outsourcing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cell Banking Outsourcing Market

• 30.1. Canada Cell Banking Outsourcing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cell Banking Outsourcing Market

• 31.1. South America Cell Banking Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cell Banking Outsourcing Market

• 32.1. Brazil Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cell Banking Outsourcing Market

• 33.1. Middle East Cell Banking Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cell Banking Outsourcing Market

• 34.1. Africa Cell Banking Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Cell Banking Outsourcing Market, Segmentation By Type, Segmentation By Cell Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cell Banking Outsourcing Market Regulatory and Investment Landscape

36. Cell Banking Outsourcing Market Competitive Landscape And Company Profiles

• 36.1. Cell Banking Outsourcing Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Cell Banking Outsourcing Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Cell Banking Outsourcing Market Company Profiles
  • 36.3.1. Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. WuXi AppTec Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Labcorp Drug Development Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Covance Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Cell Banking Outsourcing Market Other Major And Innovative Companies

• SGS Life Sciences, Sartorius AG, BioReliance, Cleancells, Clean Biologics, Texcell, Goodwin Biotechnology Inc., Perfectus Biomed Limited, BioStorage Technologies Inc., Toxikon Corp., PX'Therapeutics SA, Sigma-Aldrich Co. Ltd., Transcell Biolife Pvt Ltd, Eurofins Scientific SE, ViruSure GmbH

38. Global Cell Banking Outsourcing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cell Banking Outsourcing Market

40. Cell Banking Outsourcing Market High Potential Countries, Segments and Strategies

• 40.1 Cell Banking Outsourcing Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Cell Banking Outsourcing Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Cell Banking Outsourcing Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer